Literature DB >> 7977603

Pneumatic retinopexy for the treatment of giant retinal dialyses.

S E Melgen, M Michels.   

Abstract

PURPOSE: We sought to evaluate the effectiveness of pneumatic retinopexy as an alternative technique for retinal detachment repair in patients with retinal dialyses that were greater than three clock hours in size and located in the superior eight clock hours of the retina.
METHODS: We reviewed four consecutive cases of retinal detachment secondary to large superior retinal dialyses, extending at least three clock hours, that were successfully treated with pneumatic retinopexy.
RESULTS: Follow-up ranged from nine to 28 months. All patients had postoperative corrected visual acuity of 20/40 or better. Within two years, one patient was noted to have a new break in the inferior retina not contiguous with the original dialysis that was successfully repaired with laser photocoagulation.
CONCLUSION: Pneumatic retinopexy offers a less invasive alternative to scleral buckling surgery in certain cases of superior retinal dialyses.

Entities:  

Mesh:

Year:  1994        PMID: 7977603     DOI: 10.1016/s0002-9394(14)72556-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

Review 1.  View 3: The case for pneumatic retinopexy.

Authors:  E R Holz; W F Mieler
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Pneumatic retinopexy for treatment of posterior pole detachment following vitreoretinal surgery for diabetic tractional retinal detachment threatening the fovea.

Authors:  Mae-Lynn Catherine Bastion
Journal:  BMJ Case Rep       Date:  2012-08-08

3.  Pneumatic retinopexy: the evolution of case selection and surgical technique. A twelve-year study of 302 eyes.

Authors:  P E Tornambe
Journal:  Trans Am Ophthalmol Soc       Date:  1997

Review 4.  Pneumatic retinopexy: patient selection and specific factors.

Authors:  Stephen Stewart; Wing Chan
Journal:  Clin Ophthalmol       Date:  2018-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.